CA · CA · CA-DIN-02490099

ESPEROCT

ATC B02BD02

Last synced from Health Canada Drug Product Database (Canada) on June 11, 2026

Identification

ManufacturerNOVO NORDISK CANADA INC

CountryCA (CA)

ATC codeB02BD02

Dispensing—

ReimbursedNo

SourceHealth Canada Drug Product Database (Canada)

Last synced6/11/2026

Packs · 0

No packs registered.

Annotations

No annotations yet.

Raw payload (JSON)

{
  "din": "02490099",
  "form": "POWDER FOR SOLUTION",
  "class": "Human",
  "routes": [
    "INTRAVENOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "B02BD02",
  "schedule": [
    "Schedule D"
  ],
  "drug_code": "98016",
  "strengths": [
    "2000 UNIT"
  ],
  "ahfs_class": null,
  "substances": [
    "ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED"
  ],
  "product_categorization": null
}

Related drugs

Other records sharing ATC code B02BD02.

Access this data programmatically

Query ESPEROCT and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs